Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Cutaneous | 5 | 2020 | 14 | 1.620 |
Why?
|
| Prostatic Neoplasms | 6 | 2024 | 269 | 1.450 |
Why?
|
| Quality of Life | 7 | 2024 | 461 | 1.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 277 | 1.090 |
Why?
|
| Patient Participation | 1 | 2020 | 52 | 0.670 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 446 | 0.630 |
Why?
|
| Decision Making | 1 | 2020 | 169 | 0.620 |
Why?
|
| African Americans | 3 | 2018 | 348 | 0.590 |
Why?
|
| Health Services | 2 | 2018 | 12 | 0.580 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2019 | 56 | 0.580 |
Why?
|
| Male | 18 | 2024 | 12817 | 0.500 |
Why?
|
| Students, Pharmacy | 2 | 2024 | 73 | 0.500 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 912 | 0.500 |
Why?
|
| Adult | 14 | 2024 | 7350 | 0.490 |
Why?
|
| Advisory Committees | 1 | 2024 | 31 | 0.480 |
Why?
|
| Middle Aged | 12 | 2024 | 6790 | 0.470 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 60 | 0.450 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 908 | 0.440 |
Why?
|
| Public Health | 1 | 2024 | 84 | 0.440 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 981 | 0.410 |
Why?
|
| Education, Pharmacy | 1 | 2024 | 103 | 0.400 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 121 | 0.380 |
Why?
|
| Health Status Indicators | 1 | 2020 | 25 | 0.360 |
Why?
|
| Palliative Care | 1 | 2021 | 79 | 0.360 |
Why?
|
| Humans | 19 | 2024 | 26741 | 0.350 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 49 | 0.350 |
Why?
|
| Aged | 8 | 2024 | 5152 | 0.340 |
Why?
|
| Models, Theoretical | 1 | 2020 | 129 | 0.340 |
Why?
|
| Female | 12 | 2024 | 14402 | 0.330 |
Why?
|
| Education, Graduate | 1 | 2018 | 8 | 0.300 |
Why?
|
| Acculturation | 1 | 2018 | 15 | 0.300 |
Why?
|
| Health Expenditures | 1 | 2018 | 29 | 0.300 |
Why?
|
| Cancer Survivors | 1 | 2018 | 37 | 0.300 |
Why?
|
| Hydrocodone | 1 | 2017 | 3 | 0.290 |
Why?
|
| United States | 5 | 2024 | 2025 | 0.290 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 117 | 0.280 |
Why?
|
| Community Pharmacy Services | 1 | 2017 | 22 | 0.280 |
Why?
|
| Pharmacists | 1 | 2017 | 69 | 0.270 |
Why?
|
| Models, Psychological | 1 | 2016 | 80 | 0.260 |
Why?
|
| Depression | 1 | 2018 | 209 | 0.260 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 102 | 0.260 |
Why?
|
| Students | 1 | 2018 | 188 | 0.260 |
Why?
|
| Stress, Psychological | 1 | 2018 | 207 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 82 | 0.250 |
Why?
|
| Attitude to Health | 1 | 2015 | 86 | 0.240 |
Why?
|
| Focus Groups | 2 | 2020 | 89 | 0.230 |
Why?
|
| Oklahoma | 2 | 2024 | 968 | 0.230 |
Why?
|
| Young Adult | 5 | 2024 | 2573 | 0.230 |
Why?
|
| Smoking | 2 | 2017 | 465 | 0.210 |
Why?
|
| Neoplasms | 1 | 2021 | 748 | 0.210 |
Why?
|
| Qualitative Research | 2 | 2022 | 169 | 0.210 |
Why?
|
| Psychosocial Support Systems | 1 | 2022 | 2 | 0.200 |
Why?
|
| Behavioral Research | 1 | 2021 | 1 | 0.200 |
Why?
|
| Tobacco Products | 1 | 2015 | 189 | 0.200 |
Why?
|
| Altruism | 1 | 2020 | 8 | 0.180 |
Why?
|
| Culture | 1 | 2020 | 26 | 0.180 |
Why?
|
| Health Promotion | 1 | 2021 | 160 | 0.170 |
Why?
|
| Minority Groups | 1 | 2020 | 61 | 0.170 |
Why?
|
| Perception | 1 | 2020 | 82 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 206 | 0.160 |
Why?
|
| Adolescent | 4 | 2021 | 2945 | 0.160 |
Why?
|
| Health Status | 2 | 2020 | 145 | 0.150 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2017 | 18 | 0.150 |
Why?
|
| Texas | 3 | 2017 | 133 | 0.140 |
Why?
|
| Mass Screening | 1 | 2017 | 141 | 0.130 |
Why?
|
| Body Image | 2 | 2020 | 15 | 0.130 |
Why?
|
| Community Participation | 1 | 2024 | 25 | 0.120 |
Why?
|
| Community-Based Participatory Research | 1 | 2024 | 32 | 0.120 |
Why?
|
| Health Policy | 1 | 2024 | 59 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2024 | 111 | 0.110 |
Why?
|
| Africa, Western | 1 | 2022 | 2 | 0.100 |
Why?
|
| World Health Organization | 1 | 2022 | 10 | 0.100 |
Why?
|
| Curriculum | 1 | 2024 | 257 | 0.100 |
Why?
|
| Prostate | 1 | 2022 | 51 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 237 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 1924 | 0.100 |
Why?
|
| Health Education | 1 | 2021 | 68 | 0.090 |
Why?
|
| Pandemics | 1 | 2022 | 165 | 0.090 |
Why?
|
| Fatigue | 1 | 2020 | 57 | 0.090 |
Why?
|
| Linear Models | 1 | 2020 | 202 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 297 | 0.090 |
Why?
|
| Skin | 1 | 2020 | 139 | 0.080 |
Why?
|
| Psychometrics | 1 | 2019 | 117 | 0.080 |
Why?
|
| Internationality | 1 | 2018 | 31 | 0.080 |
Why?
|
| Canada | 1 | 2018 | 58 | 0.080 |
Why?
|
| Pain | 1 | 2020 | 252 | 0.070 |
Why?
|
| Controlled Substances | 1 | 2017 | 2 | 0.070 |
Why?
|
| Drug and Narcotic Control | 1 | 2017 | 6 | 0.070 |
Why?
|
| Universities | 1 | 2018 | 115 | 0.070 |
Why?
|
| Workflow | 1 | 2017 | 22 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2017 | 66 | 0.070 |
Why?
|
| Risk Factors | 2 | 2017 | 2008 | 0.070 |
Why?
|
| Directive Counseling | 1 | 2016 | 1 | 0.070 |
Why?
|
| Palpation | 1 | 2016 | 7 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 748 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 36 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2016 | 51 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2016 | 31 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2016 | 51 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 139 | 0.070 |
Why?
|
| Logistic Models | 1 | 2016 | 397 | 0.060 |
Why?
|
| Marijuana Smoking | 1 | 2015 | 31 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2426 | 0.060 |
Why?
|
| Age Factors | 1 | 2016 | 713 | 0.060 |
Why?
|
| Ethiopia | 1 | 2021 | 9 | 0.050 |
Why?
|
| South Africa | 1 | 2021 | 14 | 0.050 |
Why?
|
| Nigeria | 1 | 2021 | 17 | 0.050 |
Why?
|
| Child | 1 | 2016 | 2134 | 0.040 |
Why?
|
| Flagellin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Operon | 1 | 1998 | 40 | 0.040 |
Why?
|
| Bacillus subtilis | 1 | 1998 | 23 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 1998 | 106 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 76 | 0.040 |
Why?
|
| Income | 1 | 2017 | 38 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 332 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 131 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 385 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 110 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1998 | 115 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1998 | 152 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 573 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 398 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1034 | 0.010 |
Why?
|